BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34050974)

  • 1. Transformation of lymphomatoid papulosis type D to CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
    Gill P; Chia J; Street L; Mahe E
    Histopathology; 2021 Sep; 79(3):442-444. PubMed ID: 34050974
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
    Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
    Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphomatoid papulosis and progression to T-cell immunoblastic lymphoma.
    Morgan KW; Callen JP
    J Eur Acad Dermatol Venereol; 1998 May; 10(3):280-1. PubMed ID: 9643341
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report.
    Muraoka K; Fujimoto M; Iwahashi Y; Matsuzaki I; Yonei N; Murata SI; Jinnin M
    J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8
    Deenen NJ; Koens L; Jaspars EH; Vermeer MH; Willemze R; de Rie MA; Bekkenk MW
    Br J Dermatol; 2019 Feb; 180(2):411-412. PubMed ID: 30259963
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
    Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
    Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
    [No Abstract]   [Full Text] [Related]  

  • 7. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; MagaƱa M; Requena L; Simonitsch I; Cerroni L
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
    Vergier B
    Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
    Cardoso J; Duhra P; Thway Y; Calonje E
    Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type D lymphomatoid papulosis simulating aggressive epidermotropic cytotoxic lymphoma.
    Mani V; George R; Vijayakumar K; Nair S
    Indian J Pathol Microbiol; 2016; 59(1):81-3. PubMed ID: 26960644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent agmination of lymphomatoid papulosis: not a new entity, but localized lymphomatoid papulosis.
    Steinhoff M; Assaf C; Sterry W
    J Am Acad Dermatol; 2008 Jul; 59(1):164-5; author reply 165. PubMed ID: 18571601
    [No Abstract]   [Full Text] [Related]  

  • 12. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
    Simo OC; Warren SJ; Mark L; Hoffmann K; Alomari AK
    Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous T-cell lymphoma.
    Perez A; Whittaker S
    Br J Hosp Med (Lond); 2006 Apr; 67(4):178-83. PubMed ID: 16681303
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive epidermotropic cutaneous CD8+ lymphoma.
    DI Meo N; Stinco G; Trevisini S; Croatto M; Trevisan G
    G Ital Dermatol Venereol; 2016 Dec; 151(6):730-732. PubMed ID: 27824230
    [No Abstract]   [Full Text] [Related]  

  • 15. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
    Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
    Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis].
    Plettenberg H; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2003 Apr; 54(4):366-8. PubMed ID: 12669213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evolution of lymphomatoid papulosis.
    Khoo ABS; Ghura V
    Br J Haematol; 2018 Sep; 182(6):756. PubMed ID: 29808923
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermotropic CD8 positive lymphoproliferative diseases: histological and immunophenotypic similarities but markedly differing clinical behaviour.
    Paton DJ; Van Vliet C; Prasad Kumarasinghe S; Chan JJ; Wood BA
    Pathology; 2016 Dec; 48(7):733-736. PubMed ID: 27814904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous lymphomas: new entities and rare variants].
    Kempf W; Mitteldorf C
    Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.